UniSart® nitrocellulose membranes have been designed to be the ideal solid phase for Lateral Flow, able to bind high amount of capture reagent and yield a controlled and fast wicking of samples. Developed in the mid–80 for pregnancy testing, more than a billion Lateral Flow Immunoassays are today produced per year. Many markers such as cardiac, cancer, drug abuse and more can be analysed on such a strip. Like an ELISA it uses the powerful antibody/antigen reaction but in a one-step format.
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically.